PharmacoEconomics Italian Research Articles

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Valutazione economica del vaccino antinfluenzale adiuvato con virosomi in Italia nella popolazione anziana
PharmacoEconomics Italian Research Articles - Tập 15 - Trang 101-109 - 2013
R. Gasparini, C. Lucioni, S. Mazzi, D. Amicizia, D. Panatto
According to WHO, seasonal influenza affects 5–15% of population. Its burden (hospitalizations and deaths) is particularly heavy on elderly people. The only effective means of combating influenza is vaccination, and adjuvanted vaccines optimize the immune response. This work aims at evaluating the economic convenience of a virosomal vaccine in preventing hospitalization for influenza and pneumonia... hiện toàn bộ
La valutazione dei benefici e dei costi dei dispositivi medici. Il caso degli stent medicati
PharmacoEconomics Italian Research Articles - Tập 7 - Trang 195-206 - 2013
G. Scroccaro, G. Steffenino, P. Marini, S. Trippoli, B. Santarlasci
From a regulatory viewpoint, medical devices are managed differently from drugs under several aspects, such as marketing authorisation, reimbursement procedures, price negotiations. In general, medical devices have a much lower degree of regulatory control as compared to drugs. To address these critical issues, in 2002 the Italian Ministry of Health has instituted a national committee (CUD, Commis... hiện toàn bộ
Il Progetto Ipertensione negli Accordi Integrativi Locali fra FIMMG e AUSL di Ferrara: i risultati di un’esperienza
PharmacoEconomics Italian Research Articles - Tập 11 - Trang 165-173 - 2009
G. R. Marinelli, C. Casaroli, N. Vita, R. Finessi, A. Fiorini, F. Levato, A. Campi, F. Foglietta, G. L. Colombo
Cardiovascular disease (CV) is the most common cause of death and permanent disability in industrialized countries and hypertension is among the most important CV risk factors. From 2001 to 2007, the Ferrara Local Health Authority (AUSL) in collaboration with the Italian Federation of Family Doctors (FIMMG) within the Local Supplementary Agreements (AIL), developed a working plan known as “Hyperte... hiện toàn bộ
Costi della gastroenterite da rotavirus acquisita in comunità in età pediatrica a Padova in Italia
PharmacoEconomics Italian Research Articles - Tập 9 - Trang 103-111 - 2013
C. Giaquinto, S. Callegaro, B. Andreola, M. Bernuzzi, L. Cantarutti, R. D’Elia, S. Drago, A. De Marchi, P. Falconi, M. Felice, G. Giancola, C. Lista, C. Manni, M. Perin, F. Pisetta, A. Scamarcia, M. P. Sidran, N. Largeron, M. Trichard, L. Da Dalt
Rotavirus gastroenteritis (RVGE) has a major impact in terms of morbidity in Italy. Comprehensive data on the economic impact are needed in order to evaluate the cost-effectiveness of a Rotavirus (RV) vaccination program. As part of a prospective observational study (REVEAL) conducted in 2004–2005 in seven European countries, we calculated the average costs per case with confirmed RVGE in primary ... hiện toàn bộ
La ricerca farmacoeconomica italiana su riviste internazionali
PharmacoEconomics Italian Research Articles - - 2013
F. Polcaro
Analisi di costo-efficacia della terapia combinata con pioglitazone nel trattamento del diabete mellito di tipo 2 in Italia
PharmacoEconomics Italian Research Articles - - 2004
Carlo Lucioni, S. Mazzi, Kurt Neeser
La ricerca farmacoeconomica italiana su riviste internazionali
PharmacoEconomics Italian Research Articles - Tập 7 - Trang 155-162 - 2013
R. Ravasio
Impiego di un’associazione fissa di formoterolo e budesonide nel trattamento del paziente asmatico
PharmacoEconomics Italian Research Articles - - 2002
Carlo Lucioni, M. Mangrella, S. Mazzi, C Negrini, Adriano Vaghi
Costi ed efficacia devono essere scontati allo stesso tasso?
PharmacoEconomics Italian Research Articles - Tập 7 - Trang 5-7 - 2013
Giovanni Fattore
Analisi costo-utilità di anastrozolo versus tamoxifene nel trattamento adiuvante del carcinoma mammario precoce post-menopausale
PharmacoEconomics Italian Research Articles - Tập 9 - Trang 31-43 - 2013
Carlo Lazzaro
Objectives: To evaluate and compare healthcare-related costs and results on patients’ health state of anastrozole 1mg per os per diem and tamoxifen 20 mg per os per diem for adjuvant treatment in postmenopausal women with early breast cancer. Methods: On the grounds of the results of an international, multicenter, randomized clinical trial (anastrozole: 3,125 patients; tamoxifen: 3,116 patients), ... hiện toàn bộ
Tổng số: 156   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10